ES2084635T3 - Derivados peptidicos utiles como antagonistas de la bombesina y del peptido que libera la gastrina. - Google Patents

Derivados peptidicos utiles como antagonistas de la bombesina y del peptido que libera la gastrina.

Info

Publication number
ES2084635T3
ES2084635T3 ES90122330T ES90122330T ES2084635T3 ES 2084635 T3 ES2084635 T3 ES 2084635T3 ES 90122330 T ES90122330 T ES 90122330T ES 90122330 T ES90122330 T ES 90122330T ES 2084635 T3 ES2084635 T3 ES 2084635T3
Authority
ES
Spain
Prior art keywords
bombesin
grp
antagonists
gastric
gastrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90122330T
Other languages
English (en)
Inventor
Judson V Edwards
Bradford O Fanger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2084635T3 publication Critical patent/ES2084635T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57572Gastrin releasing peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN METODO PARA CONTROLAR EL CRECIMIENTO DE TEJIDOS TUMOROSOS, SOBRE TODO DE PEQUEÑAS CELULAS DEL PULMON Y CASCINOMAS PROSTALICOS Y SECRECCION ACIDA GASTRICA, QUE ORIGINA Y ES SINTOMA DE ULCERAS PEPTICAS ( EN EL ESOFAGO, GASTRICAS Y DUODENALES). EL TRATAMIENTO CONSISTE EN LA ADMINISTRACCION A PACIENTES QUE LO NECESITAN, DE UNA CANTIDAD EFICAZ DE UN INHIBIDOR DE TIPO BOMBESINA/GRP. SE DESCRIBEN LOS ANTAGONISTAS DE BOMBESINA/GRP QUE SON DERIVADOS DE BOMBESINA/GRP QUE OCURREN DE MANERA NATURAL Y QUE PROCESAN UN ENLACE SULFOXIDO DE TIOMETILENO O DE METILENO CONECTANDO LOS DOS AMINO ACIDOS EN EL EXTREMO TERMINAL CASBOXI IS MODIFIED. TAMBIEN SE DESCRIBE EL MODO COMO EL ANTAGONISMO CONFIRMADO UTILIZANDO UNA UNION COMPETITIVA CONVENCIONAL Y ENSAYOS BIOQUIMICOS ASI COMO PRUEBAS FISIOLOGICAS CONVENCIONALES Y UTILIZANDO ESTOS DERIVADOS EN UNA VARIEDAD DE CONDICIONES EN QUE LA BOMBESINA/GRP TOMA PARTE.
ES90122330T 1989-11-22 1990-11-22 Derivados peptidicos utiles como antagonistas de la bombesina y del peptido que libera la gastrina. Expired - Lifetime ES2084635T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44054789A 1989-11-22 1989-11-22
US60383090A 1990-10-31 1990-10-31

Publications (1)

Publication Number Publication Date
ES2084635T3 true ES2084635T3 (es) 1996-05-16

Family

ID=27032451

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90122330T Expired - Lifetime ES2084635T3 (es) 1989-11-22 1990-11-22 Derivados peptidicos utiles como antagonistas de la bombesina y del peptido que libera la gastrina.

Country Status (16)

Country Link
EP (1) EP0434979B1 (es)
JP (1) JP2927936B2 (es)
KR (1) KR910009730A (es)
CN (1) CN1051914A (es)
AT (1) ATE132501T1 (es)
AU (1) AU638775B2 (es)
CA (1) CA2030212A1 (es)
DE (1) DE69024626T2 (es)
ES (1) ES2084635T3 (es)
FI (1) FI905741L (es)
HU (1) HUT55798A (es)
IE (1) IE904211A1 (es)
IL (1) IL96402A0 (es)
NO (1) NO905038L (es)
NZ (1) NZ236114A (es)
PT (1) PT95953A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723578A (en) * 1987-09-24 1998-03-03 The Administrators Of Tulane Educational Fund Peptide analogs of bombesin
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
US5834433A (en) * 1990-07-26 1998-11-10 Merrell Pharmaceuticals Inc. Compounds and pharmaceutical uses of peptides of bombesin and GRP
JP3350701B2 (ja) * 1991-05-23 2002-11-25 メレルダウファーマスーティカルズ インコーポレイテッド ボンベシン類似体類
NZ246815A (en) * 1992-02-07 1996-02-27 Merrell Dow Pharma Phenylalanine analogs of bombesin and compositions thereof
US5410018A (en) * 1994-02-25 1995-04-25 Oregon Regional Primate Research Center Bombesin-related peptides
JP2002520054A (ja) * 1998-07-14 2002-07-09 コリクサ コーポレイション 前立腺癌の治療及び診断のための組成物及び方法
CA2523197C (en) 2003-04-22 2016-05-24 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide vectors
CN100372869C (zh) * 2006-04-18 2008-03-05 河北师范大学 棕点湍蛙抗微生物多肽及其在制药中的应用
CN101445554B (zh) * 2008-12-26 2012-06-27 辽宁师范大学 林蛙抗癌肽及其制备方法
US20150079623A1 (en) * 2012-03-18 2015-03-19 Kyushu University, National University Corporation Apparatus, system and method for analyzing disease sample
CN119104644B (zh) * 2024-09-09 2025-09-02 江苏省食品药品监督检验研究院(江苏省食品质量安全监控中心) 一种氨基酸分析仪测定海藻碘盐中有机碘的分析方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002897A1 (en) * 1987-09-24 1989-04-06 The Administrators Of The Tulane Educational Fund Therapeutic peptides

Also Published As

Publication number Publication date
FI905741A0 (fi) 1990-11-21
AU638775B2 (en) 1993-07-08
HUT55798A (en) 1991-06-28
EP0434979B1 (en) 1996-01-03
IL96402A0 (en) 1991-08-16
DE69024626T2 (de) 1996-05-15
KR910009730A (ko) 1991-06-28
HU907234D0 (en) 1991-05-28
NO905038D0 (no) 1990-11-21
JPH03261800A (ja) 1991-11-21
DE69024626D1 (de) 1996-02-15
ATE132501T1 (de) 1996-01-15
FI905741A7 (fi) 1991-05-23
JP2927936B2 (ja) 1999-07-28
AU6679390A (en) 1991-05-30
PT95953A (pt) 1991-09-13
EP0434979A1 (en) 1991-07-03
FI905741L (fi) 1991-05-23
CN1051914A (zh) 1991-06-05
NO905038L (no) 1991-05-23
CA2030212A1 (en) 1991-05-23
NZ236114A (en) 1993-04-28
IE904211A1 (en) 1991-05-22

Similar Documents

Publication Publication Date Title
EP0207956B1 (de) Hirudin-pa und dessen derivate, verfahren zu deren herstellung und deren verwendung
EP1161452B1 (de) Kovalent verbrückte insulindimere
DE60212186T2 (de) Verfahren zum Erfassen von Autoimmunkörpern von Patienten, die an rheumatischer Arthritis leiden, ein Peptid und ein Prüfwerkzeug
DK0399731T4 (da) Azaindener
BR9609006A (pt) Peptìdeo, composição farmacêutica, e, processo para tratamento dse paciente.
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
IS4884A (is) Ret bindill til örvunar vaxtar tauga og thvagfæra
DE3774294D1 (de) Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung.
Toouli et al. Actions of cholecystokinin-pancreozymin, secretin and gastrin on extra-hepatic biliary tract motility in vitro
DE69915160T2 (de) Verfahren zur Herstellung des Somatostatin Analogons Octreotide
ATE156492T1 (de) Bombesinanaloge
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
DE3878231D1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
US4623716A (en) Process for the preparation and purification of peptides
FI905741A0 (fi) Peptider.
DK87190A (da) Fremgangsmaade til at regulere plantevaekst under anvendelse af svovlholdige organiske syrer
ES2104637T3 (es) Peptidos con una actividad antagonista para la bombesina/grp.
EP1212351A1 (de) Verfahren zur herstellung von zyklischen peptidomimetika
US4703035A (en) Human pancreatic GRF amidated fragments
EP0655462B1 (de) Lineare Adhäsionsinhibitoren
EP0241136A3 (en) Human class 1 heparin-binding growth factor
Rayan et al. Vasoactive intestinal peptide and nerve regeneration
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DE1442147A1 (de) Verfahren zum Abbau nativer Proteine unter Erhalt ihrer biologischen Aktivitaet
Aguilera et al. Regulation and Properties of Adrenal and Vascular AII Receptors

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 434979

Country of ref document: ES